Maria J. Lopez-Barragan

FDA investigator

Appears on 2 documents from 2017, mostly at sites in New York. Most often cites general requirements (21 CFR 211.160).

2
Documents on file
5.5
Observations per 483
2017
First seen
2017
Most recent

What they cite most

From 11 observations

Activity by year

2017: 2

Where

New York 1 · South Korea 1

Often inspects with

Sarah Arden· Patrick Lynch· Zhong Li

Is Maria J. Lopez-Barragan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 Samsung BioLogicsJul 25, 2017 · Yeonsu-gu, South Korea
483 Wyeth Pharmaceutical Division of Wyeth Holdings LLCMar 17, 2017 · Pearl River, New York

About this profile

What does Maria J. Lopez-Barragan inspect?

Maria J. Lopez-Barragan appears on 2 documents on file covering 2 sites, mostly in New York.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.67 and 21 CFR 211.110.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Maria J. Lopez-Barragan is dated Jul 25, 2017.